OM, an inflammation and ulceration of the mucosal membranes in the mouth and throat, is a common side effect of radiation and chemotherapy cancer treatments.1,2
* Adapted from J Support Oncol 2004;2(1):21–32
References: 1. The Joanna Briggs Institute for Evidence Based Nursing and Midwifery. Prevention and treatment of oral mucositis in cancer patients. Best Practice Evidence Based Practice Information Sheets for Health Professionals. South Australia, Australia. 1998;2(3):1-6. 2. Kintzel PE. Management of oral mucositis in cancer patients. Clin Oncol News. October 2011:1-7. 3. Silverman S Jr. Diagnosis and management of oral mucositis. Support Oncol. 2007;5(2 suppl 1):13-21. 4. Sonis ST, Elting LS, Keefe D, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer. 2004;100(9 suppl):1995-2025. 5. Biswal BM. Current trends in the management of oral mucositis related to cancer treatment. Malaysian J Med Sci. 2008;15(3):4-13. 6. Sonis ST. A biological approach to mucositis. J Support Oncol. 2004;2(1):21-32. 7. Lalla RV, Peterson DE. Treatment of mucositis, including new medications. Cancer J. 2006;12(5):348-354. 8. Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007;68(4):1110-1120. 9. Naidu MU, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy-induced and/or radiation therapy-induced oral mucositis—complicating the treatment of cancer. Neoplasia. 2004;6(5)423-431. 10. Peterson DE, Cariello A. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy. Semin Oncol. 2004;31(3 suppl 8):35-44.
IMPORTANT SAFETY INFORMATION